Navigation Links
Arable Corporation Announces New Technology for Clinical Trial Industry

PALO ALTO, Calif., Oct. 11 /PRNewswire/ -- Arable Corporation ( has announced the launch of Arable Perform to bring unique CTMS technologies to the clinical trial industry.  Whereas traditional CTMS systems have been costly and require months to implement, Perform brings CTMS and EDC capabilities without the traditionally high start-up costs.

The Arable Perform platform allows Sponsors or CROs to manage the planning and implementation of multiple trials simultaneously.  Perform also provides large Sites with the ability to manage their service delivery to multiple CROs or Sponsors.  With Perform's proprietary dashboard, stakeholders and managers are able to view real-time status of trials down to the site or subject visit.

"Our new Arable Perform platform allows us to offer our clients immediate access to clinical trial software with the shortest "Go Live" time in the industry and at a reasonable cost," stated Ary Sarkar, CEO of Arable Corporation.  "At Arable, we combine our knowledge of the clinical trial space with our technology partnerships to offer our clients a range of services from trial planning and implementation through regulatory submittal."

Arable brings a suite of services to offer the pharmaceutical and biotech industries.  With the addition of the Perform platform, Arable introduces CTMS and EDC software to complement their existing partnerships with GlobalSubmit and Quest Life Sciences.

Arable is announcing a 30 day free trial of their Perform platform to highlight the benefits to clinical organizations.  With the economic recovery continuing to affect pharma and biotech R & D budgets, Arable believes that the Perform software will save clinical organizations money and increase time to market.  Terms and conditions apply to the free offer.

Arable Corporation combines the right technology with our proven CRO services to facilitate any size clinical trial.  Arable's Regulatory Services has partnered with GlobalSubmit, the leading name in eCTDs, whose products are used exclusively by the United States FDA and top pharmas worldwide.  Arable CRO Services brings the experience of over 50 research scientists from one of the most respected CROs in India, Quest Life Sciences Pvt. Ltd. Quest's record of accomplishment includes over 300 clinical trials, an FDA approved site, and a 22,000 square foot clinical facility.

SOURCE Arable Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Results are in: Users of BodyMedias Wearable Body-Monitoring Technology Lose 3 Times More Weight
2. Frost & Sullivan Recognizes Holst Centre and imec for Its Path Breaking Wearable Energy Harvester Technology
3. Two-Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) EXPRESS(R) Stents and Bypass Surgery
4. New Overall Survival Study Results Confirm Oral Xeloda(R) plus Oxaliplatin (XELOX) is Comparable to FOLFOX-4 for the First-Line Treatment of Advanced Colorectal Cancer
5. New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation
6. SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
7. Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy
8. MultiVu Video Feed: Major Trial Demonstrates Comparable Accuracy of Virtual Colonoscopy and Standard Colonoscopy
9. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
10. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
11. Medical Simulation Corporation Signs Agreement With a Nationally Ranked Hospital
Post Your Comments:
(Date:10/11/2017)... -- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an ... Puerto Rico , where the company ... Following a comprehensive onsite assessment, ... damage, temporary loss of power and minimal water damage ... operations have resumed, and the company expects to return ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
Breaking Medicine Technology:
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... University of California Berkeley, and other leading institutions in announcing the launch of ... institutions to change the way animals are raised for food. , Founding members ...
Breaking Medicine News(10 mins):